Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • AUD/USD

    0.6510
    +0.0021 (+0.33%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.59
    +0.23 (+0.28%)
     
  • GOLD

    2,338.20
    -3.90 (-0.17%)
     
  • Bitcoin AUD

    102,605.58
    +547.80 (+0.54%)
     
  • CMC Crypto 200

    1,416.88
    -7.22 (-0.51%)
     

Why Roche Needs to Invest in At-Home Diagnostics

Why Roche Needs to Invest in At-Home Diagnostics

As the leader in medical diagnostics, Roche (OTC: RHHB.F) acted quickly to deliver valuable COVID-19 screening tests to the marketplace. Assisted by COVID-related sales, its diagnostics division is now delivering stronger growth than its larger pharmaceuticals division. Roche's medical diagnostics division saw strong growth throughout 2021 and into the begining of 2022.